Virax Biolabs Group Limited Ordinary Shares (VRAX)

NASDAQ HEALTHCARE

$0.19 -10.63% RSI 47 Neutral Add Alert

Moving Averages

SMA 200

$0.42

Price below

Company Profile

Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.11M

P/E Ratio

None

EPS

$-1.22

Beta

1.046